Ranirestat Improves Electrophysiologic but not Clinical Measures of Diabetic Polyneuropathy: A Meta-Analysis

Ranirestat, an aldose reductase inhibitor evaluated in several randomised controlled trials (RCTs) in diabetic peripheral neuropathy (DPN). However, to date, no meta-analysis has evaluated the efficacy and safety of ranirestat in DPN. We undertook this meta-analysis to address this knowledge gap. De...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutta, Deep, Mohindra, Ritin, Kumar, Manoj, Kumar, Ashok, Sharma, Meha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815196/
https://www.ncbi.nlm.nih.gov/pubmed/36618527
http://dx.doi.org/10.4103/ijem.ijem_242_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815196/
https://www.ncbi.nlm.nih.gov/pubmed/36618527
http://dx.doi.org/10.4103/ijem.ijem_242_22

Ejemplares similares